Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|January 1, 1979
In vivo activity of lymphocytes sensitized in vitro by antigen-fed macrophages: inhibition of lymphoma growthA J Treves, M Feldman, C Honsik, et al.Transplantation|October 1, 1976
Transition from T cell protection to T cell enhancement during tumor growth in an allogeneic hostY Manor, A J Treves, I R Cohen, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1978
In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. II. Characterization of two different effector activities and of suppressor cellsA J Treves, E Heidelberger, M Feldman, et al.Israel Journal of Medical Sciences|July 1, 1979
In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophagesA J Treves, E Heidelberger, M Feldman, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1976
Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigensA J Treves, B Schechter, I R Cohen, et al.Cancer|December 15, 1981
Comparison of the response to PHA and suppressor macrophage function in different age groups of cancer patients and healthy controlsA J Treves, A Horowitz, S Biran, et al.Immunopharmacology|June 1, 1982
Prostaglandin E2 secretion by subsets of human peripheral blood monocytesA J Treves, M Ligumski, Z Fuks, et al.Israel Journal of Medical Sciences|September 1, 1988
Effects of retinoic acid and phorbol ester on lymphocytes and monocytes in B-lymphocytic leukemiaA Polliack, R Leizerowitz, V Barak, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
In vivo anti inflammatory effects of the M20 IL-1 inhibitor: I. Effects on acute inflammatory parametersV Barak, D Peritt, P Yanai, et al.Leukemia & Lymphoma|October 1, 1994
The effect of human myelomonocytic leukemic cell line (M20) derived IL-1 inhibitor on human erythroid cell developmentE Fibach, M Rigel, T Peled, et al.Pageof 6